Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × nintedanib × Clear all

NCT02863055 2025-09-19

NEMO

Phase 2 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT02568449 2021-12-09

Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent

Phase 2 Completed

20 enrolled 11 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant